KHK and cancer: Many cancer cells overexpress KHK, and essential fructosuria, the genetic disorder caused by a loss of function mutation in KHK, is clinically asymptomatic and harmless, further supporting the notion that clinical inhibition of KHK may be tolerated in cancer patients.